Are vaccines enough? To end COVID-19 we need more innovation – and more access

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Arnaud Bernaert, Head, Shaping the Future of Health and Healthcare, World Economic Forum & Elissa Prichep, Project Lead Precision Medicine, World Economic Forum


  • COVID-19 will continue to cause illness and death in 2021 and beyond before vaccines are widely enough available and the virus is contained.
  • New alliances are needed to speed the journey of COVID-19 innovations from the scientist’s bench to the patient’s bedside across all countries.
  • Patent pooling seeks a business model that offers a more sustainable solution for increasing access to medical breakthroughs.

The world has arrived at a precarious juncture in the COVID-19 pandemic. The initial roll-out of vaccines has begun in a few countries, but infections and deaths are still rising globally, and it will be many months – likely more than a year in some developing countries – before vaccines are widely enough available and the virus is contained.

What that means is that COVID-19 will continue to cause a substantial amount of illness and death in 2021 and beyond. To help those who become infected with the virus, scientists, healthcare providers and governments are continuing to develop a diverse arsenal of new options for treating patients, both in the acute phase of their illness and for the growing list of chronic problems many survivors are suffering.

There is hope on the horizon. The US Food and Drug Administration is currently tracking more than 560 COVID-19 drug development programmes. But the challenge of taking a new medication from development in a lab to administration in a clinic is two-fold: first, there is the complex and expensive scientific lift of developing new interventions; second, there is the complicated task of making them accessible and affordable. For example, the most promising treatment advances to date involve monoclonal antibodies (mAbs), which are challenging to produce and distribute, currently in limited supply, and expensive – even in high-income settings.

Accelerating the journey from lab to bedside

The normal market mechanisms and incentive structures that guide the path of treatments from development to access – which are, arguably, sub-optimal in normal circumstances – are not suited to help combat a global pandemic. This is a situation that calls for new alliances that can speed the journey of COVID-19 innovations from the scientist’s bench to the patient’s bedside across all countries.

One positive development recently emerged that offers an example of multistakeholder collaboration. A united group of 21 companies representing a large portion of the world’s generic pharmaceutical manufacturers took a bold step. Though many are often competitors, they have pledged to work together to accelerate access to COVID-19 interventions in low- and middle-income countries via the non-profit Medicines Patent Pool (MPP).

MPP was established by Unitaid in 2010, and is a United Nations-backed public health organization that facilitates the development of and access to life-saving medications in low- and middle-income countries. Over the past decade, the organization has worked with product developers and generic manufacturers to secure agreements that delivered 15 billion doses of affordable breakthrough treatments for HIV and hepatitis C to 141 countries. MPP achieves this through an innovative model of negotiating voluntary agreements with patent holders to license their discoveries to a pool accessible to generic manufacturers capable of producing and distributing high-quality, affordable medical interventions.

The generic firms that have joined the MPP COVID-19 pledge have the capacity to deliver substantial amounts of conventional drugs, as seen in the last decade where the generic manufacturers have delivered over 15 billion doses of treatments through MPP licences.

Many of them are also building the infrastructure to produce more complex “biologics” – a category that includes the COVID-19 monoclonal antibody treatments.

It’s important for the world’s major pharmaceutical companies to join this effort as well. Among other things, patent pooling provides an orderly process for achieving consensus in addressing a familiar tension: generating private sector investments in biomedical innovation while ensuring equitable access to the products that emerge. This tension is especially evident today.

Balancing commercial industry imperatives with public health needs

Yet many pharmaceutical companies may worry about the implications of broadly licensing their IP to a patent pool. They include concerns that agreements designed to serve neglected populations might inadvertently erode market opportunities elsewhere. There also may be misgivings that there will be pressure to provide especially generous licensing terms for COVID-19 interventions, setting a precedent that would be applied to future negotiations for many other medical products.

But if all sides come to the table focused on the same goal – a fair solution for rapidly expanding access to COVID-19 innovations – they will find there is opportunity for crafting bespoke licences that balance commercial industry imperatives while favouring public health needs. Like the COVAX facility for improving access to vaccines and the World Health Organization’s (WHO) Access to COVID-19 Tools Accelerator (ACT A), it can help bridge a growing divide between different countries in securing the means to fight this pandemic. In fact, the WHO is looking to MPP to play a principal role in its COVID-19 Technology Access Pool (C-TAP). Health, pandemics, epidemics

What is the World Economic Forum doing about fighting pandemics?

The first human trial of a COVID-19 vaccine was administered this week.

CEPI, launched at the World Economic Forum, provided funding support for the Phase 1 study. The organization this week announced their seventh COVID-19 vaccine project in the fight against the pandemic.Davos 2019 – Press Conference: CEPI – Building a Global C…

The Coalition for Epidemic Preparedness Innovations (CEPI) was launched in 2017 at the Forum’s Annual Meeting – bringing together experts from government, business, health, academia and civil society to accelerate the development of vaccines against emerging infectious diseases and to enable access to these vaccines during outbreaks.

Coalitions like CEPI are made possible through public-private partnerships. The World Economic Forum is the trusted global platform for stakeholder engagement, bringing together a range of multistakeholders from business, government and civil society to improve the state of the world.

Organizations can partner with the Forum to contribute to global health solutions. Contact us to find out how.

Different from efforts that rely on charitable donations or philanthropic funding, patent pooling seeks a business model that offers a more sustainable solution for increasing access to medical breakthroughs.

Much as a range of treatment options are required to address COVID-19, a range of models should be employed to effectively expand access to these treatments. To be sure, negotiations over product licences, technology transfer arrangements and financing will be complex. Yet multiple stakeholders must come together to take this step if the world is to expand manufacturing, supply and ultimately access to life saving COVID-19 treatments.

the sting Milestone

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

EU officially launches its first naval mission against migrant smugglers

London, Berlin, Paris to fight over EU budget

The Free World Experience Report – LGBTQI+ health on the spot

‘Bring to life’ precious moments caught on film or tape, UN agency urges on World Day

Eurozone’s credibility rock solid

These are the ‘positive’ tipping points that could slow global warming

Is academia losing its chance to capitalize on technology?

UN human rights chief denounces grave ‘assaults’ on fundamental rights of Palestinian people

Islamophobia is driving more US Muslims to become politically engaged, suggests report

How to create a trustworthy COVID-19 tracking technology

Insurer CEOs Reveal Marketing Strategies that Communicate the True Value of Insurance Products & Services to the Customer

European Agenda on Migration four years on: Marked progress needs consolidating in face of volatile situation

Keeping cool in the face of climate change

India should ‘unlock’ freedom curbs in disputed Kashmir, urges UN human rights chief

Commission concludes that an Excessive Deficit Procedure is no longer warranted for Italy at this stage

European Commission adopted Report on the Impact of Demographic Change in Europe

Secretary-General upholds value of UN Charter for a world in turmoil

Who cares about the unity of Ukraine?

Why CEOs need to become activists in sustainability

International tourism arrivals hit record high in 2017, UN agency reports

After swallowing effortlessly the right to be forgotten time for Google Ads now to behave

President David Sassoli to visit Skopje: “Remain on the European track”

Poverty data never tells the whole story

Parliament adopts deal to improve quality of tap water and reduce plastic litter

EU-China Leaders’ meeting: Delivering results by standing firm on EU interests and values

Three UN workers killed following Benghazi car bomb attack, as Security Council meets in emergency session, honours their ‘ultimate sacrifice’

Passwords should become a thing of the past. Here’s why

Security: better access to data for border control and migration management

Six steps that can help us to tackle homelessness

Central African Republic: Guterres says UN mission committed to protecting civilians, helping stabilize country, as violence flares

Venezuelans brave torrential border river, face exploitation, abuse – UN urges greater protection

FROM THE FIELD: Weather reports come to aid of Uganda’s farmers

Mine action is at ‘the nexus’ of peace, security and development: UN official

Germany’s fiscal and financial self-destructive policies

Commission pledges €100 million to help Mozambique recover from cyclones Idai and Kenneth

UN rights chief calls for release of hundreds abducted and abused in South Sudan

Bank resolutions to remain a politically influenced affair

Coronavirus: Commission starts testing interoperability gateway service for national contact tracing and warning apps

These countries have some of the highest voter turnout in the world

Commission launches the Fit for Future Platform and invites experts to join

Four ways Europe can become a global innovation leader

Human Rights: breaches in Cambodia, Uganda and Myanmar

Ten reasons to be optimistic in 2019

The European giant tourism sector in constant growth

What cryptocurrencies will do to the integrity of politics

Guterres in Davos: ‘Dysfunctional’ response to common problems, shows need for effective multilateralism

UN chief praises Africa for keeping ‘hearts and borders open’ in refugee crisis

Here are three ways the private sector can act as a sustainability catalyst for Globalization 4.0

Ethiopia planted 350 million trees in a day. And its fight against deforestation does not stop there

ECB policy is working, but new challenges need new responses

Stuck at sea: How to save the world’s seafarers and the supply systems they support

Slight easing of G20 GDP growth in first quarter of 2018

What slums can teach us about building the cities of the future

Coronavirus: Commission concludes exploratory talks with Valneva to secure a new potential vaccine

Employment and Social Developments in Europe review: why social fairness and solidarity are more important than ever

We have the tools to beat climate change. Now we need to legislate

Security Council urges ‘maximum restraint’ around Gulf region as Iran and United States trade diplomatic blows in New York

People, not technology, shape the future of manufacturing

Excise duties: Commission welcomes agreement on rules governing alcohol

Does hosting a World Cup make economic sense?

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s